Liver Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are able to read, understand, and follow the study's consent and requirements
- People aged 18 years or older
- People who have been diagnosed with one of these cancers: renal cell carcinoma (a type of kidney cancer), transitional cell carcinoma (a cancer affecting the bladder or urinary tract), non-small cell lung cancer, or hepatocellular carcinoma (a type of liver cancer)
- People who are being treated with a type of cancer medication known as a PD-1 or PD-L1 inhibitor (a type of immunotherapy)
- People who have not yet started their first cycle of PD-1 or PD-L1 inhibitor treatment
- People who are willing to remain involved in the study for its entire duration
Who may not be able to join:
- Women who are pregnant, breastfeeding, or planning to become pregnant during the study period
- Men who are planning for their partner to become pregnant during the study period
- Women of childbearing potential who are unable to agree to use a medically accepted and reliable form of birth control throughout the study and for one month after the last dose of study medication
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 972-3-6947832
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
To correlate Gal-3 levels with patient outcomes, including response to treatment, duration of response, survival, and side effects observed.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.